Press Releases
August 31, 2023
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
August 2, 2023
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
June 16, 2023
Coherus to Acquire Surface Oncology
May 4, 2023
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
April 18, 2023
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
March 16, 2023
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023
March 9, 2023
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
February 28, 2023
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
February 2, 2023
Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference
January 5, 2023
Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors